HM Payson & Co’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.54K | Hold |
50
| – | – | ﹤0.01% | 1020 |
|
|
2025
Q4 | $1.48K | Hold |
50
| – | – | ﹤0.01% | 1083 |
|
|
2025
Q3 | $1.29K | Hold |
50
| – | – | ﹤0.01% | 1036 |
|
|
2025
Q2 | $1.38K | Hold |
50
| – | – | ﹤0.01% | 951 |
|
|
2025
Q1 | $1.42K | Hold |
50
| – | – | ﹤0.01% | 984 |
|
|
2024
Q4 | $2.08K | Sell |
50
-106
| -68% | -$5.07K | ﹤0.01% | 958 |
|
|
2024
Q3 | $10.4K | Buy |
156
+5
| +3% | +$459 | ﹤0.01% | 832 |
|
|
2024
Q2 | $17.9K | Buy |
151
+10
| +7% | +$1.26K | ﹤0.01% | 778 |
|
|
2024
Q1 | $15K | Hold |
141
| – | – | ﹤0.01% | 779 |
|
|
2023
Q4 | $14K | Sell |
141
-244
| -63% | -$20.5K | ﹤0.01% | 785 |
|
|
2023
Q3 | $39.8K | Buy |
385
+2
| +0.5% | +$223 | ﹤0.01% | 623 |
|
|
2023
Q2 | $46.5K | Buy |
383
+1
| +0.3% | +$133 | ﹤0.01% | 587 |
|
|
2023
Q1 | $58.6K | Buy |
382
+10
| +3% | +$1.65K | ﹤0.01% | 545 |
|
|
2022
Q4 | $66.8K | Sell |
372
-290
| -44% | -$47.4K | ﹤0.01% | 522 |
|
|
2022
Q3 | $78K | Buy |
662
+300
| +83% | +$45.5K | ﹤0.01% | 507 |
|
|
2022
Q2 | $52K | Buy |
362
+55
| +18% | +$7.86K | ﹤0.01% | 571 |
|
|
2022
Q1 | $53K | Buy |
307
+6
| +2% | +$1.01K | ﹤0.01% | 591 |
|
|
2021
Q4 | $76K | Buy |
301
+156
| +108% | +$45.6K | ﹤0.01% | 540 |
|
|
2021
Q3 | $56K | Buy |
145
+2
| +1% | +$738 | ﹤0.01% | 574 |
|
|
2021
Q2 | $34K | Buy |
143
+3
| +2% | +$536 | ﹤0.01% | 657 |
|
|
2021
Q1 | $18K | Hold |
140
| – | – | ﹤0.01% | 780 |
|
|
2020
Q4 | $15K | Buy |
140
+100
| +250% | +$10.1K | ﹤0.01% | 824 |
|
|
2020
Q3 | $3K | Hold |
40
| – | – | ﹤0.01% | 927 |
|
|
2020
Q2 | $3K | Buy |
+40
| New | +$2.19K | ﹤0.01% | 822 |
|
Other funds holding MRNA
VCM
VPM
